Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00638222 · ClinicalTrials.gov registry record · NA
Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease
A NA study, sponsored by University of Toledo Health Science Campus.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT00638222 is a NA study that was terminated before completion, run by University of Toledo Health Science Campus. The registered enrollment target is 6 participants.
The verdict
NCT00638222, a NA study, was terminated before completion, sponsored by University of Toledo Health Science Campus.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Evaluate effectiveness of Carvedilol CR on Micro T-Wave Alternans in high risk hypertensives
Interventions
- OTHER Carvedilol and Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00638222
The ClinicalTrials.gov registry entry for NCT00638222 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Toledo Health Science Campus, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carvedilol and Placebo is the first listed.
NCT00638222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00638222 about?
NCT00638222 is a clinical study titled "Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease". Evaluate effectiveness of Carvedilol CR on Micro T-Wave Alternans in high risk hypertensives
What is the current status of trial NCT00638222?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2008-05. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00638222?
The interventions under investigation include: Carvedilol and Placebo (OTHER).
Who is sponsoring clinical trial NCT00638222?
This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.